Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05062343
Other study ID # 2021P002625
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2022
Est. completion date July 19, 2023

Study information

Verified date October 2023
Source Brigham and Women's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to compare Cook balloon and Dilapan-S for outpatient cervical ripening to see if Dilapan-S is non-inferior in increasing Bishop score compared to the Cook balloon.


Description:

Upon presentation for cervical ripening appointment, a sterile vaginal exam will be completed to assign Bishop score, as per standard routine. Once the patient has been consented and randomized, the participant will have a Cook catheter or Dilapan-S inserted. For the Cook catheter, the uterine component of the balloon will be inflated to maximum 60mL, the vaginal balloon will not be inflated per standard practice and per the literature that shows slightly increased pain and negligible improvement in cervical ripening. The catheter will be taped to the inner thigh with gentle traction. For Dilapan-S, 3-5 dilators will be placed. After placement, the patient will be discharged home with strict return precautions per the outpatient cervical ripening protocol. Patients must return to labor and delivery within 24 hours of cervical ripening agent placement at their scheduled inpatient induction time. Upon return to labor and delivery, if not already expelled, the mechanical ripening device will be removed, and an examiner blinded to the cervical ripening method will complete a sterile vaginal exam to assign a Bishop score. At that point health care providers will manage active labor per usual practice. Labor interventions are at the discretion of the healthcare provider. The need for operative delivery or cesarean section will be at the discretion of the healthcare provider.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date July 19, 2023
Est. primary completion date July 19, 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - 18-50 years of age - Term (37-41 6/7 weeks gestational age) - Low risk (i.e. without any maternal or fetal co-morbidity) and who are candidates for outpatient cervical ripening per the Brigham and Women's outpatient cervical ripening protocol - Singleton pregnancy - Cephalic presentation Exclusion Criteria: - Prior cesarean section - Any contraindication to outpatient cervical ripening per Brigham and Women's outpatient cervical ripening protocol - Non-English-speaking

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Dilapan-S
Osmotic dilator
Cook Cervical Ripening Balloon
Double balloon catheter for cervical ripening

Locations

Country Name City State
United States Brigham and Women's HospitaL Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Brigham and Women's Hospital

Country where clinical trial is conducted

United States, 

References & Publications (4)

Ausbeck EB, Jauk VC, Xue Y, Files P, Kuper SG, Subramaniam A, Casey BM, Szychowski JM, Harper LM, Tita AT. Outpatient Foley Catheter for Induction of Labor in Nulliparous Women: A Randomized Controlled Trial. Obstet Gynecol. 2020 Sep;136(3):597-606. doi: 10.1097/AOG.0000000000004041. — View Citation

Grobman WA, Rice MM, Reddy UM, Tita ATN, Silver RM, Mallett G, Hill K, Thom EA, El-Sayed YY, Perez-Delboy A, Rouse DJ, Saade GR, Boggess KA, Chauhan SP, Iams JD, Chien EK, Casey BM, Gibbs RS, Srinivas SK, Swamy GK, Simhan HN, Macones GA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Labor Induction versus Expectant Management in Low-Risk Nulliparous Women. N Engl J Med. 2018 Aug 9;379(6):513-523. doi: 10.1056/NEJMoa1800566. — View Citation

Saad AF, Villarreal J, Eid J, Spencer N, Ellis V, Hankins GD, Saade GR. A randomized controlled trial of Dilapan-S vs Foley balloon for preinduction cervical ripening (DILAFOL trial). Am J Obstet Gynecol. 2019 Mar;220(3):275.e1-275.e9. doi: 10.1016/j.ajog.2019.01.008. Epub 2019 Feb 18. — View Citation

Saunders SJ, Saunders R, Wong T, Saad AF. Out-of-Hospital Cervical Ripening With a Synthetic Hygroscopic Cervical Dilator May Reduce Hospital Costs and Cesarean Sections in the United States-A Cost-Consequence Analysis. Front Public Health. 2021 Jun 18;9:689115. doi: 10.3389/fpubh.2021.689115. eCollection 2021. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Bishop Score Difference in Bishop score calculated from exam at time of device removal minus Bishop score calculated from exam at time of device placement. Bishop score, or cervical score, ranges from a minimum of 0 to maximum of 13. Higher scores indicate that the cervix is more favorable, or ready for labor. Thus, change in Bishop score could range from -13 to +13 with a higher number showing more change in the score, or more cervical ripening. Up to 24 hours
Secondary Patient Satisfaction Patient Satisfaction score based on patient survey. Range from 0 (unsatisfied) to 10 (highly satisfied). Assessed upon device removal, within 24 hours
Secondary Mode of Delivery: Vaginal Delivery, Cesarean Delivery Mode of delivery, vaginal (including spontaneous vaginal, forceps and vacuum) and cesarean delivery Assessed at the time of delivery, within 1 week
Secondary Time on Labor and Delivery Time from admission on labor and delivery until delivery. Measured in hours. Assessed at the time of delivery, within 1 week
Secondary Maternal Length of Stay Admission Date/Time to Discharge Date/Time Assessed at end of study period (week 4)
Secondary Cervical Ripening Success Score: No Failure, Failure Failure defined by: inability to place intervention agent or need for further cervical ripening after removal Assessed at the time of device removal, within 24 hours
Secondary Composite Maternal Morbidity: Morbidity, no Morbidity Morbidity defined as any one of the following: higher-order laceration, blood transfusion, endometritis, wound infection, venous thromboembolism, hysterectomy, ICU admission or death Assessed at end of study period (week 4)
Secondary Composite Neonatal Morbidity: Morbidity, no Morbidity Morbidity defined as any one of the following: culture-proven neonatal sepsis, neonatal blood transfusion, hypoxic-ischemic encephalopathy, intraventricular hemorrhage grade 3 or 4, or therapeutic hypothermia Assessed at end of study period (week 4)
See also
  Status Clinical Trial Phase
Completed NCT03730220 - The Norwegian Induction Project: a Pilot for a Prospective National Audit
Completed NCT05100264 - Effect of Acidic Vaginal pH on the Efficacy of Dinoprostone for Labor Induction N/A
Completed NCT05037617 - The REDUCED-I Pilot Trial: REDucing the Utilization of CEsarean Sections With Induction N/A
Recruiting NCT06272591 - Comparison of Patient Satisfaction With Home Induction and In-patient Induction.
Completed NCT03670836 - Comparison of Misoprostol Ripening Efficacy With Dilapan Phase 4
Completed NCT04017247 - Continuous Versus Intermittent Oxytocin Infusion for Induction of Labor N/A
Completed NCT02788305 - Effect of Maternal Obesity on Labour Induction in Postdate Pregnancy N/A
Terminated NCT04004845 - Labor Protocol Study
Recruiting NCT06053073 - Induction to Labour With Double Cervical Ballon at Home Versus at Hospital N/A
Completed NCT04645823 - Spinal Fentanyl or Epidural Analgesia in the Early First Phase of Induced Labor Phase 4
Completed NCT04746248 - Outpatient Labor Induction Using Oral Misoprostol in Norway N/A
Recruiting NCT05671224 - Visual Aids for Induction of Labor RCT N/A
Completed NCT04756089 - Stimulation Therapy for Inducing Mothers N/A
Recruiting NCT05798728 - Outpatient Transcervical Balloon For Induction of Labor N/A
Withdrawn NCT04739683 - Cervical Ripening With Foley Bulb Versus Dilapan-S at Home N/A
Not yet recruiting NCT04307199 - Membrane Sweeping to Prevent Post-term Pregnancy: The MILO Study N/A
Completed NCT03725397 - Inpatient Versus Outpatient Foley Cervical Ripening Study N/A
Recruiting NCT05719467 - SAINT: Safe Induction of Labor Trial Phase 3
Completed NCT03113227 - Value of Measuring Cervical Angle and Length by Ultrasound in Prediction of Successful Induction of Delivery N/A